Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000121334 | SCV000203003 | benign | not specified | 2018-06-22 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000121334 | SCV000539614 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Invitae | RCV000860147 | SCV001000095 | benign | Multiple endocrine neoplasia, type 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV002227065 | SCV002506314 | benign | not provided | 2023-11-30 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000860147 | SCV004359140 | benign | Multiple endocrine neoplasia, type 1 | 2018-03-23 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000121334 | SCV000085508 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Genome Diagnostics Laboratory, |
RCV000121334 | SCV001978091 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000121334 | SCV001978533 | benign | not specified | no assertion criteria provided | clinical testing |